Allogeneic hematopoietic stem cell transplantation after reduced intensity conditioning regimen for elderly patients (60 years and older) with hematologic malignancies using unrelated donors: a retrospective study from the French society for stem cell transplantation (SFGM-TC)

• Jean El Cheikh,
• Patrick Sfumato,
• Mohamad Sobh,
• Nathalie Fegueux,
• Mohamad Mohty,
• Stephane Vigouroux,
• Yves Beguin,
• Ibrahim Yakoub-Agha,
• Gerard Socié,
• Jerome Cornillon,
• Melanie Mercier,
• Jacques Olivier Bay,
• Didier Blaise,
• Mauricette Michallet,
• Regis Peffault de Latour

Affiliations

Jean El Cheikh

Hematology and Oncology Bone Marrow Transplantation Program, American University of Beirut, Medical Center Beirut, Lebanon

Patrick Sfumato

Clinical Trial Office and Biostatistics Unit, Paoli Calmettes Institute, Marseille, France

Mohamad Sobh

Hematology Department, University Hospital Center, Lyon, France

Nathalie Fegueux

Hematology Department, University Hospital Center, Montpellier, France

Mohamad Mohty

Hematology and cellular therapy unit, AP-HP, Université Paris 6, Hôpital Saint Antoine, Paris, France

Stephane Vigouroux

Hematology Department, Haut-Leveque Hospital and Bordeaux University Hospital Center, Pessac, France

Yves Beguin

Hematology department, Centre Hospitalier Universitaire de Liège, Liège University, Liège, Belgium

Ibrahim Yakoub-Agha

Hematology Department, University Hospital Center, Lille, France

Gerard Socié

Hematology and cellular therapy unit, AP-HP, Hôpital Saint Louis, Paris, France

Jerome Cornillon

Hematology Department, Saint-Etienne University Hospital, Saint-Etienne, France

Melanie Mercier

Hematology Department, University Hospital Center, Angers, France

Jacques Olivier Bay

Hematology Department, University Hospital Center, Clermont-Ferrand, France

Didier Blaise

Hematology Department, transplantation unit, Paoli Calmettes Institute, Marseille, France

Mauricette Michallet

Hematology Department, University Hospital Center, Lyon, France

Regis Peffault de Latour

Hematology and cellular therapy unit, AP-HP, Hôpital Saint Louis, Paris, France